Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The marketplace dynamics of atherectomy devices are encouraged by a combination of technological improvements, the growing prevalence of cardiovascular diseases, and a growing emphasis on minimally invasive interventions for vascular conditions. The market dynamics encompass a diverse range of atherectomy strategies catering to distinctive anatomical locations and plaque traits. Directional, rotational, orbital, and laser atherectomy are several of the techniques used, presenting healthcare vendors with options to address specific affected persons' needs and optimize procedural effects. The aging global populace contributes notably to the superiority of cardiovascular sicknesses and, consequently, the demand for atherectomy devices. As individuals age, the risk of atherosclerosis and related vascular situations increases, causing the need for powerful and minimally invasive treatment options.
The market is impacted by way of the increasing instances of Peripheral Artery Disease (PAD), a commonplace manifestation of atherosclerosis affecting the arteries of doors the coronary heart. Atherectomy devices are broadly used in treating PAD, and the developing prevalence of this situation contributes to the expansion of the atherectomy devices market. The marketplace dynamics involve a fashion toward hybrid methods in vascular interventions. Atherectomy devices are often used in aggregate with different strategies, such as angioplasty and stenting. Multidisciplinary collaboration amongst interventional cardiologists, vascular surgeons, and radiologists is crucial for optimizing patient consequences and increasing the scope of atherectomy processes. The availability of repayment for atherectomy techniques affects market dynamics. Changes in compensation guidelines and the inclusion of atherectomy offerings in compensation frameworks affect the adoption of those gadgets, ensuring that healthcare providers are incentivized to offer these interventions to patients.
The marketplace is witnessing a shift closer to appearing atherectomy procedures in outpatient settings. This shift is facilitated by the minimally invasive nature of atherectomy, permitting quicker restoration times and reduced health center stays. The availability of medical proof supporting the efficacy and protection of atherectomy devices, alongside the incorporation of recommendations for their use, plays an essential position in marketplace dynamics. Evidence-based total practices and standardized pointers contribute to the establishment of first-rate practices and enhance the confidence of healthcare vendors in adopting atherectomy strategies. Variations in healthcare infrastructure, ailment occurrence, and the right of entry to advanced clinical technologies make contributions to the global dynamics of the atherectomy devices marketplace. The competitive panorama of the atherectomy devices market involves collaborations and strategic partnerships among enterprise players.
Atherectomy Devices Market Highlights:
Global Atherectomy Devices Market Overview
In addition, the global atherectomy devices market is expected to reach USD 0.84 billion by 2032 at 12.1% CAGR during the forecast period 2023-2032.
Atherectomy devices refer to various minimally invasive instruments used for peripheral vascular intervention procedures. They are designed to re-establish blood flow in the arteries by drilling, grinding, shaping, sanding, and to vaporize plaque, calcifying lesions and excessive cellular material. Some commonly used atherectomy devices include direction, orbital, photo-ablative, rotational, and support. The devices consist of a rotating blade inside a tubular catheter attached to a battery-operated motor that spins the cutter and removes the plaque or calcified lesion. As a result, atherectomy devices find extensive applications in hospitals, surgical centers and ambulatory care centers.
Atherectomy Devices Market Trends
The increasing prevalence of peripheral artery disease, atherosclerosis, diabetes and obesity and the rising geriatric population across the globe represent the key factors driving the market's growth. Furthermore, the growing preference for atherectomy surgical procedures among patients and healthcare providers is creating a positive outlook for the market. These devices reduce the risks of infections, cause minimal pain and trauma during the surgery and facilitate faster recovery of the patient. Additionally, various product innovations, such as the development of drug-coated balloons, are acting as other growth-inducing factors. The drug-coated balloons are used in place of permanent implants with directional atherectomy and anti-restenosis therapy to deliver antiproliferative drugs and treat lesions with severe calcifications.
Atherectomy Devices Market Segment Insights
The atherectomy devices market is segmented on the basis of product type, application, and end user.
The atherectomy devices market, by product type is categorised into directional atherectomy systems, orbital atherectomy systems, photo-ablative (laser) atherectomy systems, rotational atherectomy systems, and others.
The directional atherectomy systems segment is expected to hold the largest share owing to the high treatment rate, whereas the photo-ablative (laser) atherectomy systems is expected to be the fastest growing segment owing to the growing preference by surgeons.
Based on application, the atherectomy devices market is segmented into cardiovascular, neurovascular, peripheral vascular, and others.
On the basis of end user, the market is segmented into hospitals, ambulatory surgery centers, and others.
On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and Latin America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, South Korea, and the rest of Asia-Pacific. The atherectomy devices market in the Middle East and Africa has been segmented into the Middle East and Africa.
Atherectomy Devices Regional Insights
It is projected that the Americas dominated the atherectomy devices market owing to the growth of the market in the North American region. This is largely attributed to the factors such as increase in research funding, and growing awareness about the high-end atherectomy devices among medical professionals. Europe is expected to hold the second largest share in the market owing to growing healthcare infrastructure. Additionally, various initiatives by public and private organizations is anticipated to boost the growth of the market. Asia-Pacific was projected to be the fastest growing region for the market. This owes to the technological advancements resulting in the development of cost-effective atherectomy devices leading to high acceptance rate for the devices in the Asia-Pacific region. The Middle East and Africa holds the least share in the atherectomy devices market due to the presence of economically diverse countries, and less initiatives taken by the government.
Atherectomy devices market, Key Players
- Abbott
- Avinger
- Braun Melsungen AG
- Biomerics
- Biotronik
- Boston Scientific Corporation
- R. Bard
- Cardinal Health
- Koninklijke Philips
- Minnetronix, Inc.
- Straub Medical
Atherectomy Devices Market Segmentation
Atherectomy Devices Product Type Outlook
- Directional Atherectomy Systems
- Orbital Atherectomy Systems
- Photo-Ablative (Laser) Atherectomy Systems
- Rotational Atherectomy Systems
- Others
Atherectomy Devices Application Outlook
- Cardiovascular
- Neurovascular
- Peripheral Vascular
- Others
Atherectomy Devices End User Outlook
- Hospitals
- Ambulatory Surgery Centers
- Others
Atherectomy Devices Regional Outlook
- Americas
- North America
- US
- Canada
- Latin America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- The Middle East & Africa
- Middle East
- Africa
Recent Development
October 2023Medtronic announces the launch of its new LithoClearâ„¢ Laser Atherectomy System. The LithoClear system is designed to provide physicians with a safe and effective way to treat patients with coronary artery disease (CAD).Boston Scientific announces the launch of its new Innovaâ„¢ Directional Atherectomy System. The Innova system is designed to provide physicians with a precise and controlled way to remove plaque from arteries.Philips Healthcare announces the launch of its new AngioSculptâ„¢ Rotational Atherectomy System. The AngioSculpt system is designed to provide physicians with a powerful and versatile way to treat a variety of arterial blockages.September 2023A new study published in the Journal of the American Medical Association (JAMA) finds that atherectomy devices are safe and effective for treating CAD. The study found that atherectomy devices were associated with a significant reduction in the risk of major adverse cardiovascular events (MACE).Another study published in the journal Circulation: Cardiovascular Interventions finds that atherectomy devices are effective for treating patients with peripheral artery disease (PAD). The study found that atherectomy devices were associated with a significant improvement in blood flow to the legs.Intended Audience
- Medical device companies
- Biopharmaceutical companies
- Government institutions
- Research and Development (R&D) companies
- Medical research laboratories
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
